UK Blood Contamination Scandal: Prime Minister's Apology and Delayed Justice

Updated on: May 22,2024 0

UK Blood Contamination Scandal: Prime Minister's Apology and Delayed Justice

Updated on:May 22,2024 0

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I

Updated on: April 01,2024 20

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I

Updated on:April 01,2024 20

Researchers find a clue to fighting fatal influenza

by Hudson Institute of Medical ResearchGSDMD deficiency limits the severity of IAV infection. Credit:Cell Death & Disease(2023). DOI: 10.1038/s41419-023-06258-1When influenza (or

Updated on: January 28,2024 9

Researchers find a clue to fighting fatal influenza

by Hudson Institute of Medical ResearchGSDMD deficiency limits the severity of IAV infection. Credit:Cell Death & Disease(2023). DOI: 10.1038/s41419-023-06258-1When influenza (or

Updated on:January 28,2024 9

MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainNew real-world research being presented at this year's European Congress of Clinical Microbiolo

Updated on: April 30,2024 0

MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainNew real-world research being presented at this year's European Congress of Clinical Microbiolo

Updated on:April 30,2024 0

Immunological memory after SARS-CoV-2 infection recovery

by University of FreiburgColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu

Updated on: April 22,2024 15

Immunological memory after SARS-CoV-2 infection recovery

by University of FreiburgColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu

Updated on:April 22,2024 15

Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus

by The Francis Crick InstituteColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image

Updated on: April 22,2024 19

Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus

by The Francis Crick InstituteColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image

Updated on:April 22,2024 19

How COVID-19 alters the immune system

by Ludwig Maximilian University of MunichDendritic cell. Credit: D. DudziakCOVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researcher

Updated on: April 12,2024 20

How COVID-19 alters the immune system

by Ludwig Maximilian University of MunichDendritic cell. Credit: D. DudziakCOVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researcher

Updated on:April 12,2024 20

HIV infection leaves a 'memory' in cells

by George Washington UniversityImage of HIV. Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManusThough antiretroviral therapy has made HIV a manageab

Updated on: April 16,2024 20

HIV infection leaves a 'memory' in cells

by George Washington UniversityImage of HIV. Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManusThough antiretroviral therapy has made HIV a manageab

Updated on:April 16,2024 20

Will COVID-19 vaccines need to be adapted regularly?

by Charité - Universitätsmedizin BerlinJust like thephylogenetic tree of the influenza virus subtype H3N2 (right), the phylogenetic tree of the ‘common cold’ coronavirus 229E (left) shows a

Updated on: April 12,2024 11

Will COVID-19 vaccines need to be adapted regularly?

by Charité - Universitätsmedizin BerlinJust like thephylogenetic tree of the influenza virus subtype H3N2 (right), the phylogenetic tree of the ‘common cold’ coronavirus 229E (left) shows a

Updated on:April 12,2024 11

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron

Updated on: April 12,2024 11

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron

Updated on:April 12,2024 11

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base

Updated on: April 22,2024 12

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base

Updated on:April 22,2024 12

First-in-human vaccine trial for deadly Nipah virus launched

JANUARY 11, 2024byUniversity of OxfordCredit: CC0 Public DomainThe University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.This is t

Updated on: March 25,2024 4

First-in-human vaccine trial for deadly Nipah virus launched

JANUARY 11, 2024byUniversity of OxfordCredit: CC0 Public DomainThe University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.This is t

Updated on:March 25,2024 4